Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sucampo Pharma Inc (SCMP) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 499,445
  • Shares Outstanding, K 46,460
  • Annual Sales, $ 230,060 K
  • Annual Income, $ 18,490 K
  • 36-Month Beta 1.38
  • Price/Sales 2.15
  • Price/Cash Flow 4.42
  • Price/Book 2.96

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.15 +5.91%
on 03/15/17
12.75 -15.69%
on 03/08/17
-1.40 (-11.52%)
since 02/22/17
3-Month
10.15 +5.91%
on 03/15/17
14.20 -24.30%
on 01/04/17
-2.40 (-18.25%)
since 12/22/16
52-Week
9.62 +11.75%
on 05/06/16
17.55 -38.75%
on 11/30/16
+0.19 (+1.80%)
since 03/22/16

Most Recent Stories

More News
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Oppenheimer 27th Annual Healthcare Conference

Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the Oppenheimer 27 Annual Healthcare Conference....

SCMP : 10.75 (+0.94%)
Sucampo Pharmaceuticals (SCMP): Moving Average Crossover Alert

Sucampo Pharmaceuticals, Inc. (SCMP) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

SCMP : 10.75 (+0.94%)
Sucampo Pharmaceuticals Has Returned 22.7% Since SmarTrend Recommendation (SCMP)

SmarTrend identified a Downtrend for Sucampo Pharmaceuticals (NASDAQ:SCMP) on December 20th, 2016 at $13.87. In approximately 3 months, Sucampo Pharmaceuticals has returned 22.67% as of today's recent...

SCMP : 10.75 (+0.94%)
Sucampo (SCMP) Beats Q4 Earnings, 2017 View Reaffirmed

Sucampo Pharmaceuticals, Inc. (SCMP) reported adjusted earnings of 68 cents per share in the fourth quarter of 2016, beating the Zacks Consensus Estimate of 49 cents by 38.8%.

HSKA : 96.52 (+1.17%)
MYL : 41.70 (+0.07%)
SCMP : 10.75 (+0.94%)
RDY : 39.54 (+1.25%)
How These Healthcare Stocks are Faring? -- Synergy Pharma, Novo Nordisk, Apricus Biosciences, and Sucampo Pharma

Stock-Callers.com shifts focus on four equities in the Healthcare sector, which are Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), Novo Nordisk A/S (NYSE: NVO), Apricus Biosciences Inc. (NASDAQ: APRI), and...

SCMP : 10.75 (+0.94%)
NVO : 33.90 (+0.65%)
APRI : 2.26 (+1.80%)
SGYP : 4.56 (-1.94%)
Sucampo Announces Fourth Quarter and Full Year 2016 Earnings Call

Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its fourth quarter and full year 2016 financial results teleconference and webcast...

SCMP : 10.75 (+0.94%)
Shire (SHPG) Beats on Q4 Earnings, Sales; Gives Upbeat View

Shire's (SHPG) fourth-quarter results were encouraging with the company beating both top- and bottom-line estimates.

SCMP : 10.75 (+0.94%)
SHPG : 174.15 (+0.58%)
SNSS : 4.02 (-4.96%)
GSK : 42.28 (-0.09%)
Zoetis (ZTS) Beats Q4 Earnings Estimates, Lowers Outlook

Zoetis Inc. (ZTS) topped earnings estimates in the fourth-quarter of 2016 while revenues came in line. The company also narrowed its outlook for 2017 to account for currency impact.

SCMP : 10.75 (+0.94%)
ZTS : 53.87 (+0.90%)
SNSS : 4.02 (-4.96%)
GSK : 42.28 (-0.09%)
Prothena (PRTA) Reports Wider-than-Expected Loss in Q4

Prothena's wider-than-expected loss in the fourth quarter was disappointing.

SCMP : 10.75 (+0.94%)
PRTA : 51.73 (+1.85%)
RHHBY : 31.5450 (+0.43%)
SNSS : 4.02 (-4.96%)
Gilead (GILD) Announces Data on Combination Therapy for HIV

Gilead Sciences, Inc. (GILD) recently announced positive data from a phase II study on HIV cocktail therapy.

SCMP : 10.75 (+0.94%)
GILD : 67.83 (+0.13%)
ABBV : 65.52 (+0.26%)
GSK : 42.28 (-0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Sucampo Pharmaceuticals, Inc. is an emerging pharmaceutical company focused on the discovery, development and commercialization of proprietary drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. Sucampo is focused on developing prostones...

See More

Support & Resistance

2nd Resistance Point 10.98
1st Resistance Point 10.87
Last Price 10.75
1st Support Level 10.57
2nd Support Level 10.38

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.